🇺🇸 FDA
Pipeline program

TLX-101-Tx + Lomustine

131I-TLX-101-003

Phase 3 other active

Quick answer

TLX-101-Tx + Lomustine for Neoplastic Disease is a Phase 3 program (other) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Telix Pharmaceuticals Ltd
Indication
Neoplastic Disease
Phase
Phase 3
Modality
other
Status
active

Clinical trials